Covered recipient · General Payments record
ANTHONY D BOXRUD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,824.44
- Reported across 99 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $361.12 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $176.48 | 9 |
| PFIZER INC. | $49.75 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $46.29 | 2 |
| Acerta Pharma LLC | $35.87 | 2 |
| Lilly USA, LLC | $18.88 | 1 |
| Astellas Pharma US Inc | $17.24 | 1 |
| Abbott Laboratories | $16.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.61 | 02/01/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1124985905 | CMS |
| ABBVIE INC. | $31.93 | 01/13/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106808674 | CMS |
| ABBVIE INC. | $24.65 | 01/16/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106808676 | CMS |
| ABBVIE INC. | $11.94 | 01/29/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106808678 | CMS |
| ABBVIE INC. | $28.35 | 02/07/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106808680 | CMS |
| ABBVIE INC. | $9.58 | 03/12/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106808682 | CMS |
| ABBVIE INC. | $20.18 | 03/14/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106808684 | CMS |
| ABBVIE INC. | $14.67 | 04/12/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106808686 | CMS |
| ABBVIE INC. | $14.52 | 04/24/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106808688 | CMS |
| ABBVIE INC. | $20.66 | 05/24/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1106808690 | CMS |
| Astellas Pharma US Inc | $17.24 | 08/26/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1139526330 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.34 | 02/15/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1105607183 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.53 | 02/29/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1105647556 | CMS |
| Lilly USA, LLC | $18.88 | 03/25/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1135537523 | CMS |
| PFIZER INC. | $21.69 | 05/17/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1132006936 | CMS |
| PFIZER INC. | $28.06 | 08/02/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1131772535 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.91 | 01/30/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1137716865 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $27.38 | 04/09/2024 | Food and Beverage | Undisputed | 06/30/2026 | 1137716867 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.